General Information of Drug (ID: DMC8NDX)

Drug Name
SL-701
Indication
Disease Entry ICD 11 Status REF
Glioblastoma of brain 2A00.00 Phase 2 [1]
Cross-matching ID
TTD ID
D0W8TQ

References

1 ClinicalTrials.gov (NCT02078648) Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme. U.S. National Institutes of Health.